Updated Jul 16, 2026 · Last SEC filing 2026-07-02
Monopar Therapeutics (MNPR) has filed 4 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 7 Form 8-K material event filings were reported by MNPR in the last 90 days. 2 Form 144 notices of proposed sale were filed for MNPR stock. InsiderAlpha tracks every MNPR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001645469 |
| Form 4 filings (90d) | 4 |
|---|---|
| Form 8-K filings (90d) | 7 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Vu Quan Anh | Chief Financial Officer | F — Tax withholding / forfeiture | 507 | $92.59 | $47K | SEC | |
| Cittadine Andrew | Chief Operating Officer | F — Tax withholding / forfeiture | 2.3K | $92.59 | $214K | SEC | |
| Vu Quan Anh | Chief Financial Officer | M — Option exercise | 1.2K | — | — | SEC | |
| Cittadine Andrew | Chief Operating Officer | M — Option exercise | 5.3K | — | — | SEC | |
| Robinson Chandler | Chief Executive Officer | F — Tax withholding / forfeiture | 4.1K | $92.59 | $378K | SEC | |
| Robinson Chandler | Chief Executive Officer | M — Option exercise | 12.9K | — | — | SEC | |
| Robinson Chandler | Chief Executive Officer | F — Tax withholding / forfeiture | 2.0K | $54.79 | $108K | SEC | |
| Cittadine Andrew | Chief Operating Officer | M — Option exercise | 3.5K | — | — | SEC | |
| Cittadine Andrew | Chief Operating Officer | F — Tax withholding / forfeiture | 1.6K | $54.79 | $86K | SEC | |
| Robinson Chandler | Chief Executive Officer | M — Option exercise | 6.7K | — | — | SEC | |
| Cittadine Andrew | Chief Operating Officer | M — Option exercise | 4.3K | — | — | SEC | |
| Robinson Chandler | Chief Executive Officer | F — Tax withholding / forfeiture | 2.6K | $81.67 | $216K | SEC | |
| Robinson Chandler | Chief Executive Officer | M — Option exercise | 8.7K | — | — | SEC | |
| Cittadine Andrew | Chief Operating Officer | F — Tax withholding / forfeiture | 1.9K | $81.67 | $155K | SEC | |
| Tactic Pharma LLC | 10% Owner | S — Open-market sale | 550.2K | $63.61 | $35.00M | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Monopar Therapeutics (MNPR). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Robinson Chandler | 3 | $378K |
| Cittadine Andrew | 3 | $214K |
| Vu Quan Anh | 3 | $47K |
| Sweeny Nicole | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MNPR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live MNPR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.